Citigroup
JUNS

Citigroup’s Jupiter Neurosciences JUNS Stock Holding History

Citigroup’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117 Buy
+7
New +$166 ﹤0.01% 5519
2025
Q4 		– Sell
-166
Closed -$21.9K – 6592
2025
Q3 		$21.9K Buy
166
+18
+12% +$2.05K ﹤0.01% 4792
2025
Q2 		$11.3K Sell
148
-1,345
-90% -$76.9K ﹤0.01% 5167
2025
Q1 		$68.3K Buy
1,493
+1,433
+2,388% +$233K ﹤0.01% 4784
2024
Q4 		$48K Buy
+60
New +$45.3K ﹤0.01% 5094

Other funds holding JUNS

VC
Vestor Capital Chicago, Illinois $1.59B AUM 51.04% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citigroup's JUNS Position: Q2 2026 in Review

Citigroup opened a new position in Jupiter Neurosciences (JUNS) in Q2 2026: 7 shares worth $117. The stake represents ﹤0.01% of the portfolio and ranks #5519 among its holdings. This is a return to the name: Citigroup previously reported a position in JUNS as recently as Q3 2025.

Citigroup first reported a position in JUNS in Q4 2024 and has held it in 5 quarters since. The position peaked at $68.3K in Q1 2025. 13 funds tracked by Wall St. Rank hold JUNS as of Q2 2026.

  • Citigroup held 7 shares of Jupiter Neurosciences worth $117 as of Q2 2026.
  • Jupiter Neurosciences was a new Citigroup position in Q2 2026.
  • Jupiter Neurosciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5519 holding.
  • Citigroup first reported a position in Jupiter Neurosciences in Q4 2024 and has held it in 5 quarters since.
  • Citigroup's Jupiter Neurosciences position peaked at $68.3K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.